Dr. Agarwal's Health Care balance sheet

As of Mar 2026

Total assets: ₹3,942cr+7.4% on Mar 2025
Shareholders' equity: ₹2,120cr+10.0% on Mar 2025
Total debt: ₹157cr−36.3% on Mar 2025
Cash and investments: ₹243cr−33.9% on Mar 2025

₹ crore except per share

Tap a line for its trend	FY26Mar 2026	FY25Mar 2025

Non-current assets
	926	708
	234	144
	736	735
	408	448
	9.2	9.3
	166	97.3
	166	97.3
	26.9	32.0
	862	705
	3,369	2,878
Current assets
	94.0	80.3
	152	264
	161	124
	90.6	104
	38.7	155
	13.4	49.9
	456	695
	23.1	18.5
	573	794
	3,942	3,672
Equity
	31.7	31.6
	1,994	1,835
	2,025	1,867
	94.2	60.2
	2,120	1,927
Liabilities
	133	157
	1,203	1,084
	1,336	1,242
	23.9	18.3
	0.6	7.0
	1,361	1,267
	24.0	89.6
	149	153
	228	189
	401	432
	9.0	3.4
	22.8	14.9
	28.8	27.6
	461	478
	1,822	1,745
	3,942	3,672
Trade payables — MSME split
	27.5	21.3
	122	132

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

AGARWALEYE₹488.70

Dr. Agarwal's Health Care Ltd.

· Pharma & Health

₹ CrorePeersAKUMS ADVENZYMES ALIVUS AARTIPHARM AARTIDRUGS APLLTD CORONA HCGMcap ₹15,482 Cr

View

In ₹ Crore except Per Share As of	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Non-current Assets
+ Property, Plant & Equipment	707.7	926.5	926.5
+ Capital Work-in-Progress	143.9	234.4	234.4
+ Goodwill	734.8	735.8	735.8
+ Other Intangibles	448.0	408.0	408.0
+ Intangibles under Development	9.3	9.2	9.2
+ Other Non-current Financial Assets	97.3	165.7	165.7
Non-current Financial Assets	97.3	165.7	165.7
+ Deferred Tax Assets	32.0	26.9	26.9
+ Other Non-current Assets	704.6	862.5	862.5
Total Non-current Assets	2,877.5	3,368.8	3,368.8
Current Assets
+ Inventories	80.3	94.0	94.0
+ Current Investments	263.7	152.3	152.3
+ Trade Receivables	123.6	160.9	160.9
+ Cash & Cash Equivalents	103.6	90.6	90.6
+ Other Bank Balances	154.5	38.7	38.7
+ Other Current Financial Assets	49.9	13.4	13.4
Current Financial Assets	695.3	455.9	455.9
+ Other Current Assets	18.5	23.1	23.1
Total Current Assets	794.1	573.0	573.0
Total Assets	3,671.6	3,941.8	3,941.8
Equity
+ Equity Share Capital	31.6	31.7	31.7
+ Other Equity / Reserves	1,835.0	1,993.8	1,993.8
Equity — Owners of Parent	1,866.6	2,025.5	2,025.5
+ Minority Interest	60.2	94.2	94.2
Total Equity	1,926.8	2,119.7	2,119.7
Liabilities
+ Borrowings — Non-current	157.3	133.3	133.3
+ Other Non-current Financial Liab	1,084.5	1,202.8	1,202.8
Non-current Financial Liabilities	1,241.8	1,336.1	1,336.1
+ Provisions — Non-current	18.3	23.9	23.9
+ Deferred Tax Liabilities	7.0	0.6	0.6
Non-current Liabilities	1,267.0	1,360.6	1,360.6
+ Borrowings — Current	89.6	24.0	24.0
+ Trade Payables	153.1	149.3	149.3
+ Other Current Financial Liab	189.2	227.7	227.7
Current Financial Liabilities	431.9	400.9	400.9
+ Provisions — Current	3.4	9.0	9.0
+ Current Tax Liabilities	14.9	22.8	22.8
+ Other Current Liabilities	27.6	28.8	28.8
Current Liabilities	477.8	461.5	461.5
Total Liabilities	1,744.8	1,822.1	1,822.1
Total Equity & Liabilities	3,671.6	3,941.8	3,941.8
Trade Payables — MSME split
+ Dues to Micro & Small — Current	21.3	27.5	27.5
+ Dues to Other Creditors — Current	131.8	121.8	121.8

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.